From Monday 11/07/2022 there will be changes to the eligibility criteria of the oral treatments for COVID-19 recommended by the Pharmaceutical Benefits Advisory Committee.
If you are tested positive for COVID-19 by PCR or medically supervised RAT, you may be eligible for antivirals treatment if you are
From 70 years of age
From 50 years of age with 2 risk factors
From 30 years of age with 2 risk factors if Aboriginal or Torres Strait Islander
The risk factors include
living in residential aged care
living with disability with multiple conditions and/or frailty (but not limited to living in supported accommodation)
neurological conditions like stroke or dementia and demyelinating conditions e.g. multiple sclerosis, Guillain-Barre Syndrome
chronic respiratory conditions including COPD, moderate or severe asthma
obesity or diabetes (type I or II requiring medication)
heart failure, coronary artery disease, cardiomyopathies
kidney failure or liver cirrhosis
living remotely with reduced access to higher level healthcare